Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer Reliability of Restaging With Combined Positron Emission Tomography and Computed Tomography

被引:33
作者
Malone, James P. [1 ]
Gerberi, Michael A. T. [1 ]
Vasireddy, Syam [2 ,4 ]
Hughes, Larry F. [1 ]
Rao, Krishna [3 ]
Shevlin, Bruce [5 ]
Kuhn, Matthew [2 ,4 ]
Collette, Dean [2 ,4 ]
Tennenhouse, Joel [2 ,4 ]
Robbins, K. Thomas [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Radiol, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[4] St Johns Hosp, Dept Radiol, Springfield, IL USA
[5] St Johns Hosp, Dept Radiat Oncol, Springfield, IL USA
关键词
SQUAMOUS-CELL CARCINOMA; STAGE-IV HEAD; RADIATION-THERAPY; FOLLOW-UP; FDG PET; DISSECTION; CHEMORADIATION; RADIOTHERAPY; UTILITY; CT;
D O I
10.1001/archoto.2009.152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess the role of combined positron emission tomography and computed tomography (PET-CT) in predicting early treatment response at the primary site and in the neck after chemoradiotherapy (CRT) for advanced squamous cell carcinoma of the head and neck (SCCHN). Design: Retrospective analysis with a median follow-up of 24 months. Setting: Academic, tertiary referral center. Patients and Interventions: Thirty-one patients who were treated with concomitant intra-arterial CRT underwent PET-CT 6 to 8 weeks after the completion of treatment. Patients with findings on the physical examination, CT, or PET-CT indicative of persistent disease underwent appropriate surgical intervention for pathological assessment. Patients with a complete clinical response were observed with routine follow-up physical examination for disease recurrence. No evidence of disease at least 6 months after the completion of PET-CT was considered confirmation of complete clinical response. Main Outcome Measures: Presence or absence of residual or recurrent disease during the follow-up period was used to calculate the sensitivity, specificity, and positive and negative predictive values of PET-CT for the primary site and the neck. Results: Assessment of tumor response at the primary site with PET-CT had a sensitivity, specificity, and positive and negative predictive values of 83%, 54%, 31%, and 92%, respectively. In patients with pretreatment N1 to N3 disease, the sensitivity, specificity, and positive and negative predictive values of posttreatment PET-CT were 75%, more than 94%, more than 75%, and 94%, respectively, and the specificity and negative predictive value for patients with pretreatment N0 disease in the neck were 92% and more than 92%, respectively. Conclusions: Negative PET-CT findings accurately determine early disease response at the primary site and in the neck. False-positive findings are common at the primary site. Patients with a negative PET-CT finding after the completion of intra-arterial CRT do not require surgical intervention.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 25 条
  • [1] Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers
    Andrade, Regiane S.
    Heron, Dwight E.
    Degirmenci, Berna
    Filho, Pedro A. A.
    Branstetter, Barton F.
    Seethala, Raja R.
    Ferris, Robert L.
    Avril, Norbert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (05): : 1315 - 1322
  • [2] Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer
    Argiris, A
    Stenson, KM
    Brockstein, BE
    Mittal, BB
    Pelzer, H
    Kies, MS
    Jayaram, P
    Portugal, L
    Wenig, BL
    Rosen, FR
    Haraf, DJ
    Vokes, EE
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (05): : 447 - 455
  • [3] Update on chemoradiotherapy for head and neck cancer
    Argiris, A
    [J]. CURRENT OPINION IN ONCOLOGY, 2002, 14 (03) : 323 - 329
  • [4] Head and neck malignancy: Is PET/CT more accurate than PET or CT alone?
    Branstetter, BF
    Blodgett, TM
    Zimmer, LA
    Snyderman, CH
    Johnson, JT
    Raman, S
    Meltzer, CC
    [J]. RADIOLOGY, 2005, 235 (02) : 580 - 586
  • [5] Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer
    Brizel, DM
    Prosnitz, RG
    Hunter, S
    Fisher, SR
    Clough, RL
    Downey, MA
    Scher, RL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1418 - 1423
  • [6] PET-CT vs contrast-enhanced CT: What is the role for each after chemoradiation for advanced oropharyngeal cancer?
    Chen, AY
    Vilaseca, I
    Hudgins, PA
    Schuster, D
    Halkar, R
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (06): : 487 - 495
  • [7] Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    Forastiere, AA
    Goepfert, H
    Maor, M
    Pajak, TF
    Weber, R
    Morrison, W
    Glisson, B
    Trotti, A
    Ridge, JA
    Chao, C
    Peters, G
    Lee, DJ
    Leaf, A
    Ensley, J
    Cooper, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) : 2091 - 2098
  • [8] Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer
    Frank, DK
    Hu, KS
    Culliney, BE
    Persky, MS
    Nussbaum, M
    Schantz, SP
    Malamud, SC
    Holliday, RA
    Khorsandi, AS
    Sessions, RB
    Harrison, LB
    [J]. LARYNGOSCOPE, 2005, 115 (06) : 1015 - 1020
  • [9] Imaging literature and terminology: When is it residual cancer and when recurrence?
    Goerres, GW
    Stoeckli, SJ
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) : 120 - 121
  • [10] Positron emission tomography in the early follow-up of advanced head and neck cancer
    Goerres, GW
    Schmid, DT
    Bandhauer, F
    Huguenin, PU
    von Schulthess, GK
    Schmid, S
    Stoeckli, SJ
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) : 105 - 109